Hinge Health initiated with a Buy at Canaccord

Canaccord initiated coverage of Hinge Health (HNGE) with a Buy rating and $52 price target Hinge is “distinguishing itself as a true innovator” disrupting the traditional physical therapy delivery system in the U.S. with its AI-powered digital platform, the analyst tells investors. The AI-driven platform fosters strong member engagement and customer experience, while integrated AI has enabled the automation of 95% of physical therapy care, adds the analyst, who views Hinge’s leadership position in digital musculoskeletal care as “defensible.”